laserson
I think there are two more factors worth touching on that make things difficult in drug discovery:
1. It feels like you're differentiating a bit but I always hear of the APIs being leaky. The selection of a target in the target discovery phase may drive which modalities are even available to try to engineer an intervention (e.g., intracellular vs extracellular targets can be addressed with different types of drugs). Clinical factors can also determine whether a particular modality is appropriate (e.g., keeping drugs refrigerated).
2. Costs create constraints that need to be applied at all the stages of the pipeline. Does gathering evidence during target discovery require a unique assay or access to very rare patient samples? What is the size of the addressable market? If you can only target a narrow patient population, it may not end up justifying the costs involved in running the clinical trials. If your chosen drug modality costs $500k to synthesize one dose, how will it be paid for?
AI for Bio has a Fuzzy API problem
Eric Lu Wins International Chopin Piano Competition
“Chance favors the prepared mind”
U.S. Government to Take Cut of Nvidia and AMD A.I. Chip Sales to China
The Elusive Virtual Cell
Alpha School: AI-powered K-12 school in 2 hrs per day
Ask HN: Tools to help families with Alzheimer's/dementia
A close family member of mine is developing Alzheimer's disease. He can still take care of himself but is getting more difficult to converse with. He loses things easily, and every once-in-a-while gives us a scare because he decides to leave the house and doesn't tell us about it.What tools, devices, apps, etc do you recommend that could improve his safety and/or quality of life (and also our...
Tzadik Records catalog now streaming
Family of Henrietta Lacks Settles with Biotech Company
Sequoia to Separate China Business as Political Tensions Rise
Ask HN: How do you manage your contacts?
My contacts are a gross tangle of partially duplicated records between Google, iPhone, etc.How do y'all manage your contacts?There have been lots of startups trying to take on various apps in people's lives (e.g., Superhuman for email, Cron for calendar, etc.). Are there companies focused on managing contacts?
Patch Bio engineers DNA for gene therapy. We build technology to make gene therapies safer and more effective, and able to address a broader range of diseases. To do that, we work at the interface of genomics, machine learning, and DNA synthesis. We are a seed-stage, venture-backed biotech startup based in New York City.
We're looking for a Computational Biologist who will be the connective tissue between the wet and dry lab. You will design DNA libraries, analyze sequencing data, and build predictive models of genetic regulation.
Check out a more detailed job description here (with contact info): https://bit.ly/patch-bio-comput-biol
https://photos.app.goo.gl/QRCgTCUas1uYnY6x5
It did feel a bit sacrilegious slicing through the binding, but overall it worked out great!
CSHL to remove James Watson's name from graduate school
Alchemab Therapeutics is a VC-backed newco that is bringing together the latest advances in antibody repertoire profiling, deep learning, and synthetic DNA libraries to discover new antibody-based drugs in a variety of disease areas including oncology and neuroscience. Alchemab aims to deliver a pipeline of targets and therapeutic candidates over the next 18 months.
We are looking for a data engineer with cloud expertise to help build and maintain our cloud/software infrastructure. This person will work closely with our bioinformatics/statistics experts to build reliable data processing pipelines and define/implement software engineering/devops best practices.
Experience with at least some of the following is a requirement:
- AWS stack, including administration and various database products
- Data storage, (relational) data modeling, workflow engines and schedulers
- Python data stack
- Distributed computing engines, such as Spark or Dask
- Docker containerization
Experience with bioinformatics, next-generation DNA sequencing (NGS), and genomics pipelines is a plus.
The ideal candidate will feel comfortable taking the lead at a small startup to define and implement devops and data engineering tasks.
If you're interested, send an email to [email protected].
Alchemab Therapeutics is a VC-backed newco that is bringing together the latest advances in antibody repertoire profiling, deep learning, and synthetic DNA libraries to discover new antibody-based drugs in a variety of disease areas including oncology and neuroscience. Alchemab aims to deliver a pipeline of targets and therapeutic candidates over the next 18 months.
We are looking for a data engineer with cloud expertise to help build and maintain our cloud/software infrastructure. This person will work closely with our bioinformatics/statistics experts to build reliable data processing pipelines and define/implement software engineering/devops best practices.
Experience with at least some of the following resources is a plus:
- AWS stack, including administration and various database products
- Data storage, (relational) data modeling, workflow engines and schedulers
- Python data stack
- Distributed computing engines, such as Spark or Dask
- Docker containerization
The ideal candidate will feel comfortable taking the lead at a small startup to define and implement devops and data engineering tasks.
If you're interested, send an email to Olivia, our head of operations: [email protected].